BiotechTube
Home/Edwards Lifesciences/Larry L. Wood
LL

Larry L. Wood

Corporate VP, Transcatheter Mitral & Tricuspid Therapies (TMTT)

Edwards Lifesciences

Therapeutic Areas

CardiovascularStructural Heart DiseaseHeart Failure

Edwards Lifesciences Pipeline

DrugIndicationPhase
SAPIEN X4 THVSymptomatic, severe, calcific aortic stenosisPivotal
EVOQUE Tricuspid Valve Replacement SystemSevere Tricuspid RegurgitationPivotal
PASCAL Precision SystemMitral/Tricuspid RegurgitationPost-Market
APTURE Transcatheter Shunt SystemHeart Failure (HFpEF/HFmrEF)Pivotal
SAPIEN M3 SystemMitral Valve RegurgitationEarly Feasibility/Pivotal

Leadership Team at Edwards Lifesciences

BZ
Bernard Zovighian
Chief Executive Officer
MA
Michael A. Mussallem
Executive Chairman
SB
Scott B. Ullem
Chief Financial Officer
DC
Daveen Chopra
Corporate VP, TAVR & Surgical Structural Heart
View full Edwards Lifesciences profile